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There are increasing evidences that dietary components and metabolic disorders affect
gene expression through epigenetic mechanisms. These observations support the notion
that epigenetic reprograming-linked nutrition is connected to the etiology of metabolic
diseases and cancer. During the last 5 years, accumulating data revealed that the nutrient-
sensing O-GlcNAc glycosylation (O-GlcNAcylation) may be pivotal in the modulation of
chromatin remodeling and in the regulation of gene expression by being part of the “his-
tone code,” and by identifying OGT (O-GlcNAc transferase) as an interacting partner of
the TET family proteins of DNA hydroxylases and as a member of the polycomb group
proteins. Thus, it is suggested that O-GlcNAcylation is a post-translational modification
that links nutrition to epigenetic. This review summarizes recent findings about the inter-
play between O-GlcNAcylation and the epigenome and enlightens the contribution of the
glycosylation to epigenetic reprograming.
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INTRODUCTION
It is widely accepted that cancer is a group of genetic diseases
initiated by a sequential acquisition of mutations leading to the
constitutive activation of oncogenes and/or the loss of function
of tumor suppressor genes. However, numerous studies demon-
strated that tumoral development also implies epigenetic modifi-
cations, i.e., an alteration of gene expression through mechanisms
that do not affect the primary sequence of DNA (1). These epige-
netic modifications include perturbations of DNA methylation
patterns (repression of tumor suppressor genes and activation
of oncogenes by hypermethylation and hypomethylation of their
promoter region, respectively) and post-translational modifica-
tion (PTM) of histone tails that drive chromatin compaction and
relaxation that is chromatin dynamics.
An increasing number of studies tend to demonstrate that the
“epigenome” is capable of integrating and transmitting nutrient
information across generations. For example, the dietary intake of
the methyl group donor folate and vitamin B12 to pregnant mice
influences the expression of the Agouti gene, whose methylation
rate defines the color of the coat of the offspring (2). It has also
been demonstrated that young mice arisen from mothers under-
nourished during the pregnancy had defects in the methylation
and in the expression of the leptin gene encoding a factor control-
ling satiety and that this phenotype was maintained in adults (3).
Therefore, it is obvious that nutrient intake or metabolic disor-
ders could influence the emergence of cancers by modifying the
epigenome (4). In this way, a recent study highlighted that, when
compared with individuals placed on a normal diet, individuals fed
a high lipid diet on a very short period exhibit a modification of the
methylome of muscular cells affecting principally genes implicated
in the inflammatory response, the reproductive system, and cancer
(5). Another recent study also showed that a deprivation in folate
led to an increase in the invasive character of human colic can-
cer cells through hypomethylation of the promoter region of the
Sonic-hedgehog oncogene and activation of the NF-κB signaling
pathway (6). Whereas these two studies among many others lend
weight to the hypothesis of a close relationship between nutritional
disorders, epigenetic reprograming, and cancer, the underlying
mechanisms are still poorly understood. Therefore, the nutrient
sensor and chromatin modifier O-GlcNAc should be specifically
considered as a candidate connecting nutrition to epigenetic and
cancer.
O-GLcNAcylation: A NUTRIENT SENSOR IMPLICATED IN
CANCER EMERGENCE
O-GlcNAcylation or O-linked β-d-N -acetylglucosaminylation is
a reversible PTM of cytosolic, nuclear, and mitochondrial pro-
teins that consists in the covalent linkage of a unique residue of
N -acetylglucosamine (GlcNAc) to serines and threonines of tar-
get proteins. O-GlcNAcylation levels are regulated by a unique
couple of enzymes: OGT (O-GlcNAc transferase) that catalyzes
the transfer of GlcNAc from UDP-GlcNAc onto the protein and
OGA (O-GlcNAcase) that hydrolyzes the residue (Figure 1). O-
GlcNAcylation levels are closely dependent upon the concen-
tration of UDP-GlcNAc, the second most abundant nucleotide
structure in the organism, ATP being the first (40 and 100 nmol/g
of tissue, respectively). The glucose, glutamine, fatty acids, uri-
dine, and ATP metabolisms converge on the hexosamine biosyn-
thetic pathway (HBP) to produce the nucleotide-sugar. Thus,
UDP-GlcNAc and O-GlcNAcylation are considered as sensors
of the nutritional state of the organism (7, 8), which can relay
the effects of an excessive food supply, malnutrition, obesity,
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FIGURE 1 |The hexosamine biosynthetic pathway and O-GlcNAcylation
are shown. The hexosamine biosynthetic pathway (HBP) whose key limiting
enzyme is GFAT (glutamine:fructose-6-phosphate amido transferase) uses
2–3% of the extracellular glucose to produce UDP-GlcNAc (uridine-di-
phospho-N -acetyl-glucosamine), the substrate that provides the GlcNAc
residue for the O-GlcNAcylation processes. This dynamic and reversible
post-translational modification of nuclear and cytosolic proteins controls the
target proteins fate according to glucose and nutrients availability: it is
therefore considered as a nutritional sensor. A single residue of GlcNAc is
transferred to a serine or a threonine residue of the protein by the unique
O-GlcNAc Transferase (OGT) and O-GlcNAcase (OGA) hydrolyzes the residue.
G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; GlcNH26P,
glucosamine-6-phosphate; GlcNAc6P: N -acetyl-glucosamine-6-phosphate;
GlcNAc1P: N -acetyl-glucosamine-1-phosphate.
and other metabolic problems that represent high risk factors
of cancerization processes (9–11), e.g., overweight and obesity
account for more than two-thirds of new cases of type-2 dia-
betes that in turn doubles colorectal cancer emergence (12). In
this way, numerous studies clearly show that O-GlcNAcylation
plays a significant role in the etiology of cancers at differ-
ent levels: (i) increased contents of O-GlcNAcylation and OGT
were characterized in different types of cancer (breast, prostate,
colon . . .); (ii) a modulation of the expression or of the activ-
ity of OGT influence the proliferation and/or the invasiveness
of cancer cells; (iii) several oncogenic and anti-oncogenic pro-
teins are modified and regulated by O-GlcNAc (p53, HIC1, c-
myc, FOXM1, NF-κB, β-catenin . . .); (iv) O-GlcNAcylation also
participates in the metabolic reprograming of cancer cells. The
different aspects of the role of O-GlcNAcylation in cancer emer-
gence have been extensively reviewed (13, 14). In recent years,
O-GlcNAcylation has also emerged as an important regulator
of chromatin dynamics since this PTM contributes both to the
extensively described chemical modifications of histones (acety-
lation, methylation, ubiquitination, phosphorylation . . .) and to
DNA methylation patterns that affect chromatin structure. The
goal of this review is to summarize recent data showing how
O-GlcNAcylation is involved in the regulation of the epigenome
(Figure 2) and consequently how it could contribute to epigenetic
reprograming.
O-GLcNAcylation: A NUTRIENT SENSOR REGULATING
CHROMATIN DYNAMICS
O-GLcNAcylation IS PART OF THE “HISTONE CODE”
The chromatin compaction status governs the accessibility of the
transcriptional machinery to DNA and so it has a crucial role
in the establishment, the maintenance, and the propagation of
gene expression patterns. The nucleosome is the basic unit of
chromatin. This is an octamer made of a tetramer of histones
H3 and H4 and of two dimers of histones H2A–H2B around
which DNA rolls up on 147 bp and is locked by the linker his-
tone H1. The chromatin organization is managed in part by a
complex network of PTMs of histones called the “histone code”
(15). Histones are methylated, acetylated, phosphorylated, ubiq-
uitinated, ADP-ribosylated, and SUMOylated (Figure 2). These
PTMs regulate the interaction of histones with DNA and the ability
to recruit chromatin remodeling complexes necessary for tran-
scription, replication, recombination, repair, and mitosis. Several
recent studies revealed that the core histones H3–H4–H2A–H2B
are also modified with O-GlcNAc, adding a supplementary level
of complexity to the histone code that is far from being entirely
deciphered (16–20). Sakabe and Hart (21) showed that the overex-
pression of OGT in HeLa cells synchronized in M-phase prevented
the increase in histone H3 Ser10 phosphorylation, whereas it atten-
uated the decrease in H3K9 acetylation and H3K27 trimethylation
observed during mitosis (22); these observations point out the
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FIGURE 2 | O-GlcNAcylation regulates the chromatin dynamics.
O-GlcNAcylation regulates chromatin compaction and accordingly
gene transcription by interfering with the other post-translational
modifications of histones that define the “histone code” and
indirectly by its complex relationship with the PcG proteins and the
TET family proteins. See the text for details. A, acetylation; G,
O-GlcNAcylation; M, methylation; P, phosphorylation; Ub,
ubiquitination.
crucial role of OGT in modifying histone H3 during mitosis.
The same laboratory was the first to report O-GlcNAcylation
of the four core histones in HeLa cells. O-GlcNAcylation lev-
els of histones, especially those of histone H3, decrease during
mitosis whereas glycosylation status of histones increases upon
heat-shock concomitantly with DNA condensation (16). Three
sites of O-GlcNAcylation were mapped by MS/MS on histone
H2A Thr101, histone H2B Ser36, and histone H4 Ser47, respec-
tively. The O-GlcNAcylation of core histones was also reported by
Zhang et al. in HEK 293 cells (18). These authors showed that the
glycosylation of histones fluctuates all along the cell cycle with a
lower level in S-phase. More particularly, histone H3 Ser10 was
identified as a site of O-GlcNAcylation and, in accordance with
Sakabe and Hart findings (21), it was observed that increasing
O-GlcNAcylation by treating cells with glucosamine was asso-
ciated with a decreased phosphorylation of histone H3 Ser10.
These data demonstrate a direct competition between phosphory-
lation and O-GlcNAcylation at histone H3 Ser10 (18). It was also
demonstrated that glucosamine induced an increase of the active
epigenetic mark H3K4Me3 concomitantly with a decrease of the
repressive mark H3K9Me3. This suggests that O-GlcNAcylation
influences indirectly the occurrence of other PTMs of histones.
The precise function of H3 Ser10 phosphorylation is still currently
not fully understood but is clearly associated with regulation of the
condensation and/or segregation of chromosomes during mitosis
(23). Intriguingly, histone H3 Ser10 phosphorylation is catalyzed
by the kinase Aurora B (24) whereas it is dephosphorylated by the
phosphatase PP1 (25). These two enzymes physically interact with
OGT and OGA in a complex located at the midbody to regulate
cytokinesis and exit from mitosis (26). In HeLa cells, Thr32 of his-
tone H3 was highlighted as another site of O-GlcNAcylation with
a higher level in interphase than in mitosis, which inversely corre-
lated with mitosis-specific phosphorylations on histone H3 (19).
The mitosis-specific phosphorylations of histone H3 at Thr32,
Ser10 (18), and Ser28 (also phosphorylated by Aurora B) (27)
are reduced by treating M-phase synchronized-cells with the two
inhibitors of OGA, PUGNAc, or thiamet G, or by overexpress-
ing OGT. Fujiki et al. identified three sites of O-GlcNAcylation of
histone H2B at Ser91, Ser112, and Ser123 (17). O-GlcNAcylation
of histone H2B at Ser112 fluctuates in response to extracellular
glucose and promotes its monoubiquitination on Lys120 by favor-
ing the interaction of histone H2B with the E3 ubiquitin ligase
complex BRE1A/B. In this study, genome-wide analysis revealed
that H2B Ser112 O-GlcNAcylation was frequently located near
transcribed genes, suggesting that histone H2B O-GlcNAcylation
facilitates gene transcription. A very recent study identified the
AMP-activated protein kinase (AMPK) as a regulator of H2B
Ser112 O-GlcNAcylation (20). AMPK is a sensor of energy sta-
tus which activity is controlled by the ATP/AMP ratio. AMPK
controls cell metabolism and cell growth in response to changes
in nutrient availability. AMPK dysfunctions are associated with
diseases including diabetes and cancers (28, 29). In their study,
Xu et al. demonstrated that activating AMPK with AICAR in
mouse embryonic fibroblasts (MEFs) resulted in a decrease in H2B
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Ser112 O-GlcNAcylation and H2B K120 ubiquitination. AMPK
directly phosphorylates OGT on Thr444; this phosphorylation
does not interfere with OGT activity per se on H2B Ser112, but it
prevents its loading on chromatin as demonstrated by ChIP exper-
iments. The authors also demonstrated that the catalytic subunit
of AMPK, AMPKα1, is O-GlcNAcylated and that the knock-down
of OGT by RNAi in MEFs led to a decrease in the activating
phosphorylation of AMPK on Thr112. As a whole, these results
highlight the occurrence of a feedback regulatory loop between
OGT and AMPK.
It was also reported that OGT and O-GlcNAcylation control
the activity of histones methyltransferases (Figure 2). OGT asso-
ciates with and modifies CARM1 (co-activator associated arginine
methyltransferase 1) (21, 30). The overexpression of OGT in HeLa
cells decreased the phosphorylation of CARM1 and its methyl-
transferase activity at Arg7 of histone H3 (H3R7) (21). MLL5, an
H3K4 histone methyltransferase and co-activator of RARα, inter-
acts with OGT in a multimeric complex (31). O-GlcNAcylation
of MLL5 Thr440 potentiates its H3K4 methyltransferase activity
and increases granulopoiesis of HL60 promyelocytes in response
to retinoic acid (31). Host cell factor 1 (HCF1) is a compo-
nent of the H3K4 methyltransferase complex SET1/COMPASS
(32, 33). O-GlcNAcylation of HCF1 enhances the stability of
the SET1/COMPASS complex. OGT is necessary for the bind-
ing of SETD1A, the component of the complex that bears the
methyltransferase activity, to chromatin (33).
In addition to the glucosaminidase activity, OGA exhibits
a histone acetyl transferase (HAT) property in its C-terminal
region and is sometimes called NCOAT for nuclear and cyto-
plasmic O-GlcNAcase and acetyl transferase (34). Therefore,
O-GlcNAcylation would be able to regulate the acetylation of
the histones tails, but this function remains controversial (35).
Whisenhunt et al. demonstrated that OGA/NCOAT, OGT, the
co-repressor Sin3A (Switch-independent 3A), and HDAC1 (His-
tone Deacetylase 1) co-exist in a complex that was named
O-GlcNAczyme (36). ChIP experiments performed in MCF7 cells
revealed a specific enrichment of the O-GlcNAczyme on promot-
ers of repressed genes (36). Nevertheless, the existence of this
O-GlcNAczyme complex has not yet been confirmed by other
studies.
O-GLcNAcylation MODIFIES MEMBERS OF THE TET FAMILY PROTEINS
In 2013, several studies, albeit sometimes contradictory, provided
compelling evidences of a close relationship among OGT, O-
GlcNAcylation, and the DNA hydroxylase properties of the TET
(Ten–Eleven Transcription) family proteins involved in the DNA
demethylation on CpG islands (Figure 2). TET1, TET2, and TET3
convert 5-methyl-cytosine (5mC) to 5-hydroxy-methyl-cytosine
(5hmC) and are necessary for gene transcription, pre-mRNA splic-
ing, and zygotic genetic reprograming (37). Chen et al. demon-
strated that OGT interacts but does not O-GlcNAcylate or influ-
ence the function of TET2 and TET3 (38). However, these authors
showed that TET2 and TET3 promote the recruitment of OGT to
the chromatin in order to modify histones (38). Such a role for
TET3 in the loading of OGT to chromatin has been also reported
by Ito et al. at the same time (39). In their study, Chen et al.
performed ChIP-Seq experiments that revealed the presence of
OGT and H2B Ser112-O-GlcNAc on a large number of TET2 tar-
get genes and more especially around transcription start sites (38).
Contrary to the observations of Chen et al., O-GlcNAcylation of
transiently transfected TET3 was reported in two other studies, but
O-GlcNAcylation of the endogenous protein was not observed (39,
40). The O-GlcNAcylation of TET1 and TET2 were also indepen-
dently reported (40–42). OGT promotes the cytoplasmic reloca-
tion of a myc-TET3 construction according to a mechanism that
remains to be deciphered whereas O-GlcNAcylation has no effect
either on TET1 or on TET2 subcellular localization (40). However,
O-GlcNAcylation of TET1 regulates its expression level in mouse
embryonic stem (ES) cells (42) and stabilizes the hydroxylase on
the promoters of target genes (41). The occurrence that OGT and
TET proteins form a complex with co-repressors reinforces the
importance of O-GlcNAcylation processes in the regulation of
gene transcription. By proteomic analyses performed in mouse
ES cells, Shi et al. demonstrated that TET1 and OGT interact
with the chromatin regulator Sin3A and with several members
of the NuRD (nucleosome remodeling and deacetylase) complex
(Figure 2) (40). The authors also found that OGT is required for
maintaining ES cells pluripotency since depletion of this enzyme
induces a derepression of several markers of differentiation (40).
The interaction between TET1, TET2, Sin3A, HCF1, and OGT
was also reported (41). In this study, using genome-wide ChIP-seq
experiments, 11552 binding sites for OGT among which 62% are
located within promoter regions were identified. A co-localization
of OGT, TET1, and H3K4Me3 was also observed near the tran-
scription start sites; this demonstrates that TET1 is necessary to
recruit OGT to the chromatin.
OGT BELONGS TO THE POLYCOMB GROUP PROTEINS
In 2009, two independent studies surprisingly revealed that the fly
geneSxc (Supersexcomb) initially characterized as a gene belonging
to the polycomb group (PcG) proteins (43) is the gene that encodes
OGT (44, 45). PcG proteins represent a family of transcrip-
tional repressors discovered in Drosophila melanogaster. These
proteins are necessary for the maintenance of the repression of
the homeotic genes (Hox) whose expression patterns govern the
establishment of the antero-posterior axis of the embryo. In mam-
mals, PcG proteins also repressed Hox genes and numerous other
genes controlling the programing of adult and ES cells, cell pro-
liferation, and differentiation. In Drosophila and mammals, PcG
proteins are found in two main large complexes, PRC1 and PRC2
(Polycomb Repressive Complexes 1 and 2), whose members have
been conserved during evolution (46). These two complexes act
in a sequential manner: first PRC2 is recruited to the promoter
region of its target genes where the histone methyl transferase
EZH2 (Enhancer of Zest Homolog 2) is responsible for H3K27 di-
and trimethylation (H3K27Me2 and H3K27Me3), a repressive epi-
genetic mark. H3K27Me3 is subsequently recognized by the chro-
modomain of the PC (Polycomb) protein, a core component of
PRC1. The catalytic activity of PRC1 is driven by the E3 ubiquitin
ligase RING that catalyzes the monoubiquitination of histone H2A
Lys119 (H2AK119Ub). The precise mechanisms by which Poly-
comb complexes repress transcription are not fully understood
Frontiers in Endocrinology | Molecular and Structural Endocrinology September 2014 | Volume 5 | Article 155 | 4
Dehennaut et al. O-GlcNAcylation, the sweet mark of epigenetic
while it involves both inhibition of the transcriptional machin-
ery and chromatin compaction and recruitment of DNA methyl
transferases (DNMTs). Polycomb responsive elements (PRE) were
characterized in Drosophila, but such nucleotide sequences are not
found in mammals. Therefore, in mammals, the mechanisms of
PRC2 recruitment to its target genes remain to be elucidated. One
proposed targeting mechanisms together with sub-stoichiometric
components of PRC2 (e.g., JRID2) or the implication of specific
long non-coding RNAs in the interaction of PRC2 components
with sequence-specific transcription factors (47). For example,
the transcriptional repressor HIC1 (Hypermethylated in cancer
1) could recruit PRC2 on a subset of target genes through its
interaction with human polycomb-like (hPCL) proteins (48). For
note, we previously demonstrated that HIC1 is O-GlcNAcylated,
but the role of its glycosylation is still not deciphered (49). In
their original study performed in Drosophila, Gambetta and col-
laborators identified by ChIP-seq experiments 1138 sites occupied
by O-GlcNAcylated proteins among which 490 colocalized with
PREs (44). The authors demonstrated a decrease of the fixation
of the polyhomeotic (PH) protein, a core component of PRC1, on
the majority of the PREs in sxc/ogt mutants in comparison with
wild-type Drosophila. The same authors also showed that PH is
itself O-GlcNAcylated (Figure 2). The catalytic core component
of PRC2 EZH2 interacts with OGT inside PRC2 and the knock-
down of OGT in MCF7 or MDA-MB231 cells led to a 50% decrease
in H3K27Me3 due to EZH2 and PRC2 destabilization (50). O-
GlcNAcylation of EZH2 has been mapped at Ser75, and the S75A
mutant is less stable than the wild-type protein (Figure 2). By
a combination of microarrays and ChIP experiments, Chu et al.
(50) identified 16 genes co-regulated by OGT and EZH2. Knock-
down of OGT affects the fixation of EZH2 and the deposit of the
repressive mark H3K27Me3 on these genes, some of which like
UNC5A or IL1R1 have been reported as tumor suppressor genes
(51, 52). A study conducted in mouse highlighted a decrease in
OGT and in nuclear O-GlcNAcylation in eed−/− and suz12−/−
ES cells, two genes encoding core components of PRC2 (53). This
set of data suggests a complex feedback relationship between O-
GlcNAcylation and PcG proteins, notably with core components
of PRC2, which remains to be fully understood.
CONCLUSION AND FUTURE DIRECTIONS
O-GlcNAcylation has recently emerged as a novel epigenetic mark
affecting chromatin remodeling and gene expression according
to several mechanisms (Figure 2). First, O-GlcNAcylation modi-
fies histone tails and depending on the residue, O-GlcNAcylation
either favors chromatin relaxation and gene transcription or
chromatin compaction and thus it prevents transcription.
O-GlcNAcylation also regulates the occurrence of other PTMs
defining the histone code and more particularly methylation by
modulating the activity of several methyltransferases like CARM1,
MLL5, and HCF1. OGT and O-GlcNAcylation regulates the activ-
ity of different co-repressors among which NuRD and mSin3A;
but, especially, O-GlcNAcylation displays a complex relationship
with the PcG proteins to prevent gene transcription. At last,
O-GlcNAcylation may promote DNA demethylation by interact-
ing with members of the TET family proteins thus favoring gene
transcription.
At this time, the crucial role played by O-GlcNAcylation in
metabolic disorders and neuronal diseases etiology is indisputable.
Regarding cancer, O-GlcNAcylation interfered with cell biology
through a large panel of mechanisms among cell proliferation,
adhesion, migration, and metabolic reprograming. In this review,
we summarized recent evidences suggesting thatO-GlcNAcylation
also highly coordinates chromatin dynamics adding a further level
of regulation of cancer emergence through O-GlcNAcylation of
the epigenome. However, the role of O-GlcNAcylation in cancer-
associated epigenetic reprograming is far from being fully deci-
phered and further studies are required to understand the impact
of aberrantO-GlcNAcylation in tumorigenesis and to identify new
targets that could be used for prevention, diagnosis, or treatment
of cancers.
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